These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3258990)
1. Inhibition of pancreatic and liver carcinogenesis in rats by retinoid- and selenium-supplemented diets. Curphey TJ; Kuhlmann ET; Roebuck BD; Longnecker DS Pancreas; 1988; 3(1):36-40. PubMed ID: 3258990 [TBL] [Abstract][Full Text] [Related]
2. Divergent effects of retinoids on pancreatic and liver carcinogenesis in azaserine-treated rats. Longnecker DS; Kuhlmann ET; Curphey TJ Cancer Res; 1983 Jul; 43(7):3219-25. PubMed ID: 6601985 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of pancreatic carcinogenesis by retinoids in azaserine-treated rats. Longnecker DS; Curphey TJ; Kuhlmann ET; Roebuck BD Cancer Res; 1982 Jan; 42(1):19-24. PubMed ID: 7053848 [TBL] [Abstract][Full Text] [Related]
4. Effects of dietary beta-carotene and selenium on initiation and promotion of pancreatic carcinogenesis in azaserine-treated rats. Appel MJ; Woutersen RA Carcinogenesis; 1996 Jul; 17(7):1411-6. PubMed ID: 8706242 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of micronutrients on pancreatic carcinogenesis in azaserine-treated rats. Appel MJ; Roverts G; Woutersen RA Carcinogenesis; 1991 Nov; 12(11):2157-61. PubMed ID: 1934304 [TBL] [Abstract][Full Text] [Related]
6. Pancreatic carcinoma in azaserine-treated rats: induction, classification and dietary modulation of incidence. Longnecker DS; Roebuck BD; Yager JD; Lilja HS; Siegmund B Cancer; 1981 Mar; 47(6 Suppl):1562-72. PubMed ID: 6974040 [TBL] [Abstract][Full Text] [Related]
7. Promotion by unsaturated fat of azaserine-induced pancreatic carcinogenesis in the rat. Roebuck BD; Yager JD; Longnecker DS; Wilpone SA Cancer Res; 1981 Oct; 41(10):3961-6. PubMed ID: 7285004 [TBL] [Abstract][Full Text] [Related]
8. Effect of dietary excess of inorganic selenium during initiation and postinitiation phases of colon carcinogenesis in F344 rats. Reddy BS; Sugie S; Maruyama H; Marra P Cancer Res; 1988 Apr; 48(7):1777-80. PubMed ID: 3349457 [TBL] [Abstract][Full Text] [Related]
9. Caloric restriction and intervention in pancreatic carcinogenesis in the rat. Roebuck BD; Baumgartner KJ; MacMillan DL Cancer Res; 1993 Jan; 53(1):46-52. PubMed ID: 8416749 [TBL] [Abstract][Full Text] [Related]
10. Effect of an inorganic and organic form of dietary selenium on the promotional stage of mammary carcinogenesis in the rat. Thompson HJ; Meeker LD; Kokoska S Cancer Res; 1984 Jul; 44(7):2803-6. PubMed ID: 6722810 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of voluntary exercise during the postinitiation phase of pancreatic carcinogenesis in the rat. Roebuck BD; McCaffrey J; Baumgartner KJ Cancer Res; 1990 Nov; 50(21):6811-6. PubMed ID: 2208145 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets. Reddy BS; Rivenson A; El-Bayoumy K; Upadhyaya P; Pittman B; Rao CV J Natl Cancer Inst; 1997 Apr; 89(7):506-12. PubMed ID: 9086007 [TBL] [Abstract][Full Text] [Related]
13. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat. Roebuck BD; Kaplita PV; Edwards BR; Praissman M Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of dietary fat promoted development of (pre)neoplastic lesions in exocrine pancreas of rats and hamsters by supplemental selenium and beta-carotene. Woutersen RA; van Garderen-Hoetmer A Cancer Lett; 1988; 42(1-2):79-85. PubMed ID: 3180038 [TBL] [Abstract][Full Text] [Related]
15. Modulation of pancreatic carcinogenesis by antioxidants. Woutersen RA; Appel MJ; Van Garderen-Hoetmer A Food Chem Toxicol; 1999; 37(9-10):981-4. PubMed ID: 10541454 [TBL] [Abstract][Full Text] [Related]
16. Dietary modulation of azaserine-induced pancreatic carcinogenesis in the rat. Roebuck BD; Yager JD; Longnecker DS Cancer Res; 1981 Mar; 41(3):888-93. PubMed ID: 7459874 [TBL] [Abstract][Full Text] [Related]
17. A single-dose protocol for azaserine initiation of pancreatic carcinogenesis in the rat. Yager JD; Roebuck BD; Zurlo J; Longnecker DS; Weselcouch EO; Wilpone SA Int J Cancer; 1981 Nov; 28(5):601-6. PubMed ID: 6975760 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305). Lhoste EF; Roebuck BD; Longnecker DS Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478 [TBL] [Abstract][Full Text] [Related]
19. Lack of inhibition by retinoids of bis(2-oxopropyl)nitrosamine-induced carcinogenesis in Syrian hamsters. Birt DF; Davies MH; Pour PM; Salmasi S Carcinogenesis; 1983 Oct; 4(10):1215-20. PubMed ID: 6577972 [TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet. Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]